This work is licensed under the Creative Commons Attribution 4.0 International License.
Inoue T, Node K. Vascular failure: A new clinical entity for vascular disease. Journal of hypertension. 2006;24(11):2121-30. DOI: 10.1097/01.hjh.0000249684.76296.4fSearch in Google Scholar
Ziaeian B, Fonarow G: Epidemiology and aetiology of heart failure. Nature Rev Cardiol. 2016;13(6):368-78. DOI: 10.1038/nrcardio.2016.25Search in Google Scholar
Narula J, Haider N, Arbustini E, Chandrashekhar Y. Mechanisms of disease: apoptosis in heart failure-seeing hope in death. Nature clinical practice Cardiovascular medicine 2006;3(12):681-8. DOI: 10.1038/ncpcardio0710Search in Google Scholar
Gaudino M, Andreotti F, Kimura T. Current concepts in coronary artery revascularisation. Lancet (London, England) 2023;401(10388):1611-28. DOI: 10.1016/S0140-6736(23)00459-2Search in Google Scholar
Agrawal R, Sharafkhaneh A, Nambi V, BaHammam A, Razjouyan J. Obstructive sleep apnea modulates clinical outcomes post-acute myocardial infarction: A large longitudinal veterans’ dataset report. Respiratory Med. 2023;211:107214. DOI: 10.1016/j. rmed.2023.107214Search in Google Scholar
Lu M, Fang F, Wang Z, Xu L, Sanderson J, Zhan X, et al. Association Between OSA and Quantitative Atherosclerotic Plaque Burden: A Coronary CT Angiography Study. Chest. 2021;160(5):1864-74. DOI: 10.1016/j.chest.2021.07.040Search in Google Scholar
Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. New England J Med. 2013;368(21):2004-2013. DOI: 10.1056/NEJMra1216063Search in Google Scholar
Björkegren J, Lusis A. Atherosclerosis: Recent developments. Cell. 2022;185(10):1630-45. DOI: 10.1016/j.cell.2022.04.004Search in Google Scholar
Daugherty A. Mouse models of atherosclerosis. Am J Med Sci. 2002;323(1):3-10. DOI: 10.1097/00000441-200201000-00002Search in Google Scholar
Zhang Y, Fatima M, Hou S, Bai L, Zhao S, Liu E. Research methods for animal models of atherosclerosis (Review). Molec Med Rep. 2021;24(6). DOI: 10.3892/mmr.2021.12511Search in Google Scholar
Morand J, Arnaud C, Pepin J, Godin-Ribuot D. Chronic intermittent hypoxia promotes myocardial ischemia-related ventricular arrhythmias and sudden cardiac death. Sci Rep. 2018;8(1):2997. DOI: 10.1038/s41598-018-21064-ySearch in Google Scholar
[Chinese guidelines for the diagnosis and treatment of heart failure 2018]. Zhonghua xin xue guan bing za zhi 2018;46(10):760-89.Search in Google Scholar
Cowie M, Gallagher A. Sleep Disordered Breathing and Heart Failure: What Does the Future Hold? JACC Heart failure. 2017;5(10):715-23. DOI: 10.1016/j.jchf.2017.06.016Search in Google Scholar
Tsai H, Han M. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation. Drugs. 2016;76(11):1067-79. DOI: 10.1007/s40265-016-0603-2Search in Google Scholar
Yu F, Yuan C, Tong J, Zhang G, Zhou F, Yang F. Protective effect of sphingosine-1-phosphate for chronic intermittent hypoxia-induced endothelial cell injury. Biochem Biophys Res Com. 2018;498(4):1016-21. DOI: 10.1016/j.bbrc.2018.03.106Search in Google Scholar
Maceyka M, Spiegel S: Sphingolipid metabolites in inflammatory disease. Nature. 2014;510(7503):58-67. DOI: 10.1038/nature13475Search in Google Scholar
Syed S, Raue R, Weigert A, von Knethen A, Brüne B. Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation. Cells. 2019;8(8). DOI: 10.3390/cells8080785Search in Google Scholar
Yoon C, Hong B, Moon H, Lim S, Suh P, Kim Y, et al. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood. 2008;112(4):1129-1138. DOI: 10.1182/blood-2007-11-125203Search in Google Scholar
Zhang J, Hu C, Jiao X, Yang Y, Li J, Yu H, et al. Potential Role of mRNAs and LncRNAs in Chronic Intermittent Hypoxia Exposure-Aggravated Atherosclerosis. Front Genet. 2020;11:290. DOI: 10.3389/fgene.2020.00290Search in Google Scholar
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics. 2008;9:559. DOI: 10.1186/1471-2105-9-559Search in Google Scholar
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al: clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141. DOI: 10.1016/j.xinn.2021.100141Search in Google Scholar
Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576-589. DOI: 10.1016/j. molcel.2010.05.004Search in Google Scholar
Zhang G, Yu F, Li Y, Wei Q, Song S, Zhou F, Tong J. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition. J Am Heart Assoc. 2017,;6(10). DOI: 10.1161/JAHA.117.006680Search in Google Scholar
Zhang J, Hu C, Jiao X, Yang Y, Li J, Yu H, et al. Potential Role of mRNAs and LncRNAs in Chronic Intermittent Hypoxia Exposure-Aggravated Atherosclerosis. Front Genetics. 2020;11:290. DOI: 10.3389/fgene.2020.00290Search in Google Scholar
Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu L, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovascular Res. 2014, 103(4):530-541. DOI: 10.1093/cvr/cvu167Search in Google Scholar
Alioglu E, Ercan E, Sonmez Tamer G, Duman C, Turk U, Tengiz I, et al. Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia. Int J Cardiol. 2011;146(3):e49-52. DOI: 10.1016/j.ijcard.2008.12.184Search in Google Scholar
Bilo G, Gatterer H, Torlasco C, Villafuerte F, Parati G. Editorial: Hypoxia in cardiovascular disease. Front Cardiovasc Med. 2022;9:990013. DOI: 10.3389/fcvm.2022.990013Search in Google Scholar
Kubasiak L, Hernandez O, Bishopric N, Webster K. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(20):12825-12830. DOI: 10.1073/pnas.202474099Search in Google Scholar
Pio-Abreu A, Moreno H, Drager L. Obstructive sleep apnea and ambulatory blood pressure monitoring: current evidence and research gaps. J Human Hypert. 2021;35(4):315-324. DOI: 10.1038/s41371-020-00470-8Search in Google Scholar
Cartier A, Hla T: Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. Science 2019;366(6463). DOI: 10.1126/science.aar5551Search in Google Scholar
Bravo G, Cedeño R, Casadevall M, Ramió-Torrentà L. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives. Cells. 2022;11(13):2058. DOI: 10.3390/cells11132058Search in Google Scholar
Psallidas I, Stathopoulos G, Maniatis N, Magkouta S, Moschos C, Karabela S, et al. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion. Oncogene. 2013;32(4):528-35. DOI: 10.1038/onc.2012.57Search in Google Scholar
Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591-619. DOI: 10.1146/annurev. immunol.021908.132706Search in Google Scholar
Lee TS, Lu TM, Chen CH, Guo BC, Hsu CP. Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway. Redox Biol. 2021;46:102108. DOI: 10.1016/j.redox.2021.102108Search in Google Scholar
Mandl M, Kapeller B, Lieber R, Macfelda K. Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions. Biochem Biophys Res Commun. 2013;434(1):166-72. DOI: 10.1016/j.bbrc.2013.03.051Search in Google Scholar
Semenza G: Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399-408. DOI: 10.1016/j.cell.2012.01.021Search in Google Scholar
Sato T, Takeda N. The roles of HIF-1α signaling in cardiovascular diseases. Journal of cardiology 2023.81(2):202-208. DOI: 10.1016/j.jjcc.2022.09.002Search in Google Scholar
Masoud G, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015 Sep;5(5):378-89. DOI: 10.1016/j.apsb.2015.05.007Search in Google Scholar
Sakai D, Sugawara T, Kurokawa T, Murakami Y, Tomosugi M, Masuta H, et al. Hif1α-dependent hypoxia signaling contributes to the survival of deep-layer neurons and cortex formation in a mouse model. Molec Brain. 2022;15(1):28. DOI: 10.1186/s13041-022-00911-0Search in Google Scholar
Bouquerel P, Gstalder C, Müller D, Laurent J, Brizuela L, Sabbadini RA, et al: Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer. Oncogenesis. 2016;5(3):e209. DOI: 10.1038/oncsis.2016.13Search in Google Scholar
Wu T, Shao Y, Li X, Wu T, Yu L, Liang J, et al. NR3C1/Glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity. Autophagy. 2023:1-20. DOI: 10.1080/15548627.2023.2200625Search in Google Scholar
Sundahl N, Bridelance J, Libert C, De Bosscher K, Beck I. Selective glucocorticoid receptor modulation: New directions with nonsteroidal scaffolds. Pharmacol Therap. 2015;152:28-41. DOI: 10.1016/j.pharmthera.2015.05.001Search in Google Scholar
Leonard M, Godson C, Brady H, Taylor C. Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J Immunol. 2005;174(4):2250-7. DOI: 10.4049/jimmunol.174.4.2250Search in Google Scholar